Continuing Treatment With Pegasys and Copegus

NCT00336518 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: peginterferon alfa-2a
DRUG: ribavirin

Sponsor

Májbetegekért Alapítvány

Collaborators

[object Object]